Colgate-Palmolive (India) Limited CFO Interaction: Premiumization playbook intact; EBITDA margin capped by reinvestment

Research evidence excerpt

Colgate-Palmolive (India) Limited CFO Interaction: Premiumization playbook intact; EBITDA margin capped by reinvestment

J P M O R G A N Asia Pacific Equity Research

09 June 2026

Colgate-Palmolive (India) Limited Neutral

COLG.NS, CLGT IN

CFO Interaction: Premiumization playbook intact; Price (09 Jun 26):Rs2,023.40

EBITDA margin capped by reinvestment Price Target (Jun-27):Rs2,250.00

We hosted Mr. MS Jacob, CFO, at the JPM India Consumer CEO/CFO Fireside Consumer, Retail, Media

ACChat series. The CFO signaled a positive FY27 outlook, towards balanced (vol, Latika Chopra, CFA

price), premiumization led revenue growth. Oral care category should be relatively (91-22) 6157-3584

resilient amidst inflation headwinds. The core growth lever is premiumization and latika.chopra@jpmorgan.com

brands like Total, Whitening, and PerioGard are being pushed disproportionately, Himanshu Singh

alongside pack-size upgrades (Rs10→Rs20, Rs20→Rs30). Price increases (91-22) 6157-3610

(~MSD) should be manageable, particularly when the category saw price himanshu.x6.singh@jpmorgan.com

reductions last year post GST rate cuts, in our view. Urban is improving (led by Saransh S Gokhale

Modern Trade and E-commerce, with Quick Commerce now accounting for half (91-22) 6157 3578

saransh.gokhale@jpmchase.com

of online revenue with accretive mix/margin/market share), while rural remains J.P. Morgan India Private Limited, J.P. Morgan

stable but more exposed to inflation risk. Long-gestation consumption-building Tower, Santacruz(E), Mumbai - 400098, SEBI

Registration: INH000001873, (91-22) 6157-3000.

initiatives (brush-twice campaigns, OHM, IPL tie-ups, school programs) underpin

medium-term volume aspirations. On the profitability front, gross margins are